Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection

Multiple Sclerosis

Volumn 16, Issue 3, 2010, Pages 303-316

  Lovas, G ^a,b   Nielsen, J A ^b,c   Johnson, K R ^b   Hudson, L D ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c Center for Devices and Radiological Health   (United States)

Author keywords

Axonal transection; Experimental demyelination; Injury response; Microarray; Rat

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; PROTIRELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DEMYELINATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NERVE POTENTIAL; NERVE TRANSECTION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REMYELINIZATION; UNINDEXED SEQUENCE;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; CASE-CONTROL STUDIES; CEREBELLUM; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOPHOSPHATIDYLCHOLINES; MALE; MULTIPLE SCLEROSIS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THYROTROPIN-RELEASING HORMONE; TIME FACTORS; TRAUMA, NERVOUS SYSTEM;

EID: 77949895494     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509357063     Document Type: Article

References (48)

1. Prineas JW, Connell F. The fine structure of chronically active multiple sclerosis plaques. Neurology 1978 ; 28: 68-75.
2. Storch M., Lassmann H. Pathology and pathogenesis of demyelinating diseases. Curr Opin Neurol 1997 ; 10: 186-192.
3. Lovas G., Palkovits M., Komoly S. A molecular element of neuronal response to lysolecithin-induced focal, experimental demyelination in rat. Neurobiology (Bp) 2000 ; 8: 273-275.
4. Trapp BD, Peterson J., Ransohoff RM, Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1-29- 1998 ; 338: 278-285.
5. Ferguson B., Matyszak MK, Esiri MM, Perry VH Axonal damage in acute multiple sclerosis lesions. Brain 1997 ; 120 (Pt 3). 393-399.
6. Lovas G., Szilagyi N., Majtenyi K., Palkovits M., Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000 ; 123 (Pt 2). 308-317.
7. Arnold DL, Wolinsky JS, Matthews PM, Falini A. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998 ; 64 (Suppl 1). S94-101.
8. De Stefano N., Matthews PM, Fu L., Narayanan S., Stanley J., Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998 ; 121 (Pt 8). 1469-1477.
9. Falini A., Calabrese G., Filippi M., Origgi D., Lipari S., Colombo B., et al. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. AJNR Am J Neuroradiol 1998 ; 19: 223-229.
10. Duncan JS Magnetic resonance spectroscopy. Epilepsia 1996 ; 37: 598-605.
11. Simmons ML, Frondoza CG, Coyle JT Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991 ; 45: 37-45.
12. Lucchinetti C., Bruck W., Noseworthy J. Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment. Curr Opin Neurol 2001 ; 14: 259-269.
13. Palkovits M. Neuropeptide messenger plasticity in the CNS neurons following axotomy. Mol Neurobiol 1995 ; 10: 91-103.
14. Agoston DV, Komoly S., Palkovits M. Selective up-regulation of neuropeptide synthesis by blocking the neuronal activity: galanin expression in septohippocampal neurons. Exp Neurol 1994 ; 126: 247-255.
15. Dumont RJ, Okonkwo DO, Verma S., Hurlbert RJ, Boulos PT, Ellegala DB, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001 ; 24: 254-264.
16. Abankwa D., Kury P., Muller HW Dynamic changes in gene expression profiles following axotomy of projection fibres in the Mammalian CNS. Mol Cell Neurosci 2002 ; 21: 421-435.
17. Del Signore A., De Sanctis V., Di Mauro E., Negri R., Perrone-Capano C., Paggi P. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur J Neurosci 2006 ; 23: 65-74.
18. Dutcher SA, Michael DB Gene expression in neurotrauma. Neurol Res 2001 ; 23: 203-206.
19. Shortland PJ, Baytug B., Krzyzanowska A., McMahon SB, Priestley JV, Averill S. ATF3 expression in L4 dorsal root ganglion neurons after L5 spinal nerve transaction. Eur J Neurosci 2006 ; 23: 365-373.
20. Yakovlev AG, Faden AI Molecular biology of CNS injury. J Neurotrauma 1995 ; 12: 767-777.
21. Greenberg SA Microarray analysis of human nervous system gene expression in neurological disease. Int Rev Neurobiol 2004 ; 60: 135-151.
22. Arnett HA, Wang Y., Matsushima GK, Suzuki K., Ting JP Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 10-29- 2003 ; 23: 9824-9832.
23. Kotter MR, Setzu A., Sim FJ, Van Rooijen N., Franklin RJ Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001 ; 35: 204-212.
24. Lovas G., Palkovits M., Komoly S. Increased c-Jun expression in neurons affected by lysolecithin-induced demyelination in rats. Neurosci Lett 10-6- 2000 ; 292: 71-74.
25. Woodruff RH, Franklin RJ Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 2-1- 1999 ; 25: 216-228.
26. Woodruff RH, Franklin RJ Growth factors and remyelination in the CNS. Histol Histopathol 1997 ; 12: 459-466.
27. Woodruff RH, Franklin RJ The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination. Neuropathol Appl Neurobiol 1999 ; 25: 226-235.
28. Fressinaud C., Jean I., Dubas F. [Lesion mechanism dependent, differential changes in neurofilaments and microtubules: a pathological and experimental study]. Rev Neurol (Paris) 2005 ; 161: 55-60.
29. Gilson J., Blakemore WF Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 1993 ; 19: 173-181.
30. Canellas AR, Gols AR, Izquierdo JR, Subirana MT, Gairin XM Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology 2007 ; 49: 393-409.
31. Halasz B., Florsheim WH, Corcorran NL, Gorski RA Thyrotrophic hormone secretion in rats after partial or total interruption of neural afferents to the medial basal hypothalamus. Endocrinology 1967 ; 80: 1075-1082.
32. Saavedra JM, Palkovits M., Brownstein MJ, Axelrod J. Localisation of phenylethanolamine N-methyl transferase in the rat brain nuclei. Nature 4-19- 1974 ; 248: 695-696.
33. Weaver DR, Deeds JD, Lee K., Segre GV Localization of parathyroid hormone-related peptide (PTHrP) and PTH/ PTHrP receptor mRNAs in rat brain. Brain Res Mol Brain Res 1995 ; 28: 296-310.
34. Herdegen T., Kovary K., Leah J., Bravo R. Specific temporal and spatial distribution of JUN, FOS, and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation. J Comp Neurol 11-1- 1991 ; 313: 178-191.
35. Mason MR, Lieberman AR, Anderson PN Corticospinal neurons up-regulate a range of growth-associated genes following intracortical, but not spinal, axotomy. Eur J Neurosci 2003 ; 18: 789-802.
36. McCampbell A., Truong D., Broom DC, Allchorne A., Gable K., Cutler RG, et al. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy. Hum Mol Genet 11-15- 2005 ; 14: 3507-3521.
37. Tsujino H., Kondo E., Fukuoka T., Dai Y., Tokunaga A., Miki K., et al. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci 2000 ; 15: 170-182.
38. Dickson TC, Adlard PA, Vickers JC Sequence of cellular changes following localized axotomy to cortical neurons in glia-free culture. J Neurotrauma 2000 ; 17: 1095-1103.
39. Tanabe K., Bonilla I., Winkles JA, Strittmatter SM Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci 10-22- 2003 ; 23: 9675-9686.
40. Verhaagen J., Zhang Y., Hamers FP, Gispen WH Elevated expression of B-50 (GAP-43)-mRNA in a subpopulation of olfactory bulb mitral cells following axotomy. J Neurosci Res 6-1- 1993 ; 35: 162-169.
41. Zein EF, Karaa SE, Rollot F., Blanche P., Chemaly RE Treatment of central pontine myelinolysis with thyrotropin-releasing hormone. Presse Med 2006 ; 35: 618-620.
42. Iwasaki Y., Shiojima T., Tagaya N., Kobayashi T., Kinoshita M. TRH-analog, TA-0910 (3-methyl(s)-5,6-dihydroorotyl-L-histidyl-L-prolinamide) rescues motor neurons from axotomy-induced cell death. Neurol Res 1997 ; 19: 613-616.
43. Fekete C., Sarkar S., Lechan RM Relative contribution of brainstem afferents to the cocaine- and amphetamine-regulated transcript (CART) innervation of thyrotropin-releasing hormone synthesizing neurons in the hypothalamic paraventricular nucleus (PVN). Brain Res 1-25- 2005 ; 1032: 171-175.
44. Kira J., Harada M., Yamaguchi Y., Shida N., Goto I. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991 ; 102: 61-66.
45. Bonilla IE, Tanabe K., Strittmatter SM Small prolinerich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci 2-15- 2002 ; 22: 1303-1315.
46. Leaner VD, Kinoshita I., Birrer MJ AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets. Oncogene 8-28- 2003 ; 22: 5619-5629.
47. Liu C., Shi Y., Du Y., Ning X., Liu N., Huang D., et al. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Exp Cell Res 10-1- 2005 ; 309: 410-418.
48. Wek RC, Jiang HY, Anthony TG Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 2006 ; 34: 7-11.